A historical argument for regulatory failure in the case of Primodos and other hormone pregnancy tests

Schering poster

REPRODUCTIVE BIOMEDICINE & SOCIETY ONLINE: Article by Jesse Olszynko-Gryn, Eira Bjørvik, Merle Weßel, Solveig Jülich, Cyrille Jean Abstract The drug Primodos and other hormone pregnancy tests (HPTs) remained on the British market for about a decade after they were first implicated, in 1967, as a possible cause of birth defects. In November 2017, an expert working group (EWG) set…

Read More